IP Library Granted Patent US 10,426,545
Granted Patent B2
US 10,426,545 · App. 14/784,509 · Granted Oct 1, 2019

Method and apparatus for percutaneous epicardial ablation of cardiac ganglionated plexi without myocardial injury

Inventors: Samuel J. Asirvatham (Rochester, MN); Mark B. Knudson (Shoreview, MN)
Assignee: Mayo Foundation for Medical Education and Research
A61B18/1492A61N1/0551A61N1/20A61B2018/00363A61B2018/00577A61B2018/00642A61B2018/0212A61B2018/1266A61B2018/1472A61N1/36057
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,426,545
App. No.
14/784,509
Granted
Oct 1, 2019
Kind
B2
Abstract

A method and device for modulating the autonomic nervous system adjacent a pericardial space to treat cardiac arrhythmia includes a treatment source arranged to supply a treatment medium, a catheter having an end sized for insertion into the pericardial space, a medium delivery assembly having a distal end arranged to be positioned by the catheter into the pericardium, with the distal end of the delivery assembly comprising a delivery tip arranged to extend away from the distal end of the catheter into the pericardial space. A connector operatively couples the delivery tip of the medium delivery assembly to the treatment source, and the delivery tip of the medium delivery assembly including a plurality of delivery points for delivering the treatment medium at a plurality of treatment areas within the pericardial space. The device performs modulation or ablation of the autonomic nervous system at selected treatment areas within the pericardium.

Claims (21)

1. A method of ablating or modulating ganglia on an epicardial surface of a heart to treat cardiac disorders, the method comprising:

sensing activity of the ganglia to identify a desired location on the epicardial surface;

placing an energy delivery assembly adjacent to the desired location, the energy delivery assembly comprising a plurality of electrodes;

coupling the energy delivery assembly to a source of non-thermal DC electrical energy;

selecting one or more characteristics of the non-thermal DC electrical energy; and

applying to the desired location, via the plurality of electrodes, the non-thermal DC electrical energy according to the selected one or more characteristics, wherein the selected one or more characteristics comprises applying the non-thermal DC electrical energy at a pulsation frequency of between 5 kHz and 10 kHz to ablate or modulate the ganglia without affecting pericardial and myocardial tissues of the heart.

2. The method of claim 1 , further comprising:

providing the delivery assembly with a delivery tip that includes the plurality of electrodes;

coupling the plurality of electrodes to a monitoring and control system;

configuring the one or more characteristics of the non-thermal DC electrical energy with the monitoring and control system.

3. The method of claim 2 , further comprising:

sensing the activity of the ganglia via one or more of the plurality of electrodes; and

interpreting in the monitoring and control system the sensed activity of the ganglia.

4. The method of claim 1 , wherein applying the non-thermal DC electrical energy comprises applying non-thermal DC modulation.

5. The method of claim 4 , wherein selecting the one or more characteristics of the non-thermal DC electrical energy comprises selecting a current level of the non-thermal DC electrical energy that is below a level that induces ventricular fibrillation.

6. The method of claim 1 , wherein the selected one or more characteristics of the non-thermal DC electrical energy comprises applying the non-thermal DC electrical energy at a frequency of between 6 and 8 kHz.

7. The method of claim 6 , further comprising synchronizing the applying the non-thermal DC electrical energy with a QRS complex of the heart.

8. The method of claim 1 , further comprising delivering a conductive solution to the desired location prior to applying the non-thermal DC electrical energy.

9. The method of claim 8 , wherein delivering the conductive solution to the desired location comprises delivering the conductive solution to the desired location via one or more apertures disposed adjacent to the plurality of electrodes.

10. The method of claim 1 , wherein placing the energy delivery assembly adjacent to the desired location comprises orienting the delivery assembly such that the plurality of electrodes is in contact with the epicardial surface and not in contact with the pericardium.

11. The method of claim 1 , wherein placing the energy delivery assembly adjacent to the desired location comprises isolating an adjacent portion of the pericardium from the plurality of electrodes.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2016
From: ASIRVATHAM, SAMUEL J.; KNUDSON, MARK B.
To: MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH
Reel/Frame 038920/0158 →
Continuity (4)
Provisional Application 61823347 · May 14, 2013
Provisional Application 61817775 · Apr 30, 2013
Provisional Application 61812114 · Apr 15, 2013
Related Publication 20160051322A1 · Feb 25, 2016
Cited By (12)
US 12,217,863 US 12,257,071 US 12,279,889 US 12,369,852 US 12,369,859 US 12,376,757 US 12,408,906 US 12,433,670 US 12,471,776 US 12,544,131 US 12,611,134 US 12,714,780